Aiforia Overview
- Founded
-
2013

- Status
-
Public
- Employees
-
67

- Stock Symbol
-
AIFORIA

- Share Price
-
$3.71
- (As of Thursday Closing)
Aiforia General Information
Description
Aiforia Technologies PLC equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more.
Contact Information
Website
www.aiforia.com
Formerly Known As
Fimmic, Webmicroscope
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Enterprise Systems (Healthcare)
Stock Exchange
HEL
Primary Office
- Biomedicum 2 U
- Tukholmankatu 8
- 00290 Helsinki
- Finland
+358 020 0000000
Aiforia Timeline
Aiforia Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$3.71 | $3.73 | $2.96 - $5.91 | $96.1M | 25.8M | 10.5K | -$0.42 |
Aiforia Financials Summary
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 74,498 | 142,728 | ||
Revenue | 1,443 | 1,152 | 968 | 715 |
EBITDA | (6,400) | (4,080) | (1,834) | (2,396) |
Net Income | (10,826) | (8,957) | (3,142) | (3,418) |
Total Assets | 42,548 | 49,668 | 6,479 | 4,747 |
Total Debt | 3,024 | 3,278 | 4,008 | 2,471 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Aiforia Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Aiforia Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Aiforia Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Aiforia Technologies PLC equips pathologists and scientists in preclinical and clinical labs with powerful deep learning
Decision/Risk Analysis
Helsinki, Finland
67
As of 2022
000.00
0000
0000-00-00
00000000
000.00
Aiforia Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
0000000000 | Venture Capital-Backed | Boston, MA | 000 | 00000 | 00000000000 | 00000 |
Aiforia Patents
Aiforia Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230016641-A1 | Processing pathology images | Active | 13-Jul-2021 | 0000000000 | |
US-11562485-B1 | Processing pathology images | Active | 13-Jul-2021 | 0000000000 | 0 |
US-11373306-B1 | Processing pathology images | Active | 13-Jul-2021 | 00000000 | 0 |
EP-4035062-A1 | Image analysis in pathology | Pending | 26-Sep-2019 | 0000000000 | |
US-20210097687-A1 | Image analysis in pathology | Active | 26-Sep-2019 | G06T7/0014 |
Aiforia Executive Team (9)
Aiforia Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Johan Lundin Ph.D | Aiforia | Co-Founder, Scientific Advisor & Board Member | 000 0000 |
John Sweeney | Epredia | Board Member | 000 0000 |
Kin Au | Aiforia | Board Member | 000 0000 |
Monita Mo | Ascend Capital Partners | Board Member | 000 0000 |
Pekka Mattila | Self | Chairman | 000 0000 |
Aiforia Signals
Aiforia Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|